Ireland· IE-PA-PA0822/126/001
Dostinex 500 microgram tablets
A cabergoline product containing cabergoline, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Cabergoline is registered in 13 of 19 countries.
Countries holding a registration under ATC G02CB03 (cabergoline), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Cabergoline · ATC G02CB03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of cabergoline costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $3.40 in France to $11.81 in Switzerland — a ×3.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cabergoline · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.81
- IT Italy$4.08
- FR France$3.40
The record
At a glance
HPRA (Ireland)- Active substance
- Cabergoline
- Manufacturer
- Pfizer Healthcare Ireland Unlimited Company
- Country
- Ireland (IE)
- ATC code
- G02CB03
- ATC class
- Cabergoline
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0822/126/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for cabergoline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cabergoline · interactions on record
65 records
- 3 severe
- 17 moderate
- 45 info
Most severe, free to view
- LorcaserinA08AA11severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cabergoline in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCabergoline 500microgram tabletsArrow Generics Ltd
- PolandDostinexDelfarma Sp. z o.o.
- United StatesCabergolineA-S Medication Solutions
- SwedenCabenex 0,5 mg TablettRenata Pharmaceuticals (Ireland) Limited
- CzechiaDOSTINEXPfizer, spol. s r.o., Praha
- FranceCABERGOLINE ARROW 0,5 mg, comprimé sécableARROW GENERIQUES
- ItalyCABERGOLINA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- NetherlandsCabergoline 0,5 PCH, tabletten 0,5 mgPharmachemie B.V.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Cabaseril, Dostinex
- Belgium · Cabergoline Teva, Dostinex
- Bulgaria · Достинекс
- Cyprus · Dostinex
- Czechia · Dostinex
- Germany · Cabaseril, Cabergoletten
- Denmark · Cabenex, Cabergolin Teva
- Spain · Cabergolina Teva, Dostinex
- Finland · Cabaser, Dostinex
- France · Cabergoline Arrow, Cabergoline Biogaran
- United Kingdom (Northern Ireland) · Cabaser, Cabergoline Aspire Pharma
- Greece · Dostinex
- Croatia · Dostinex
- Iceland · Dostinex
- Italy · Cabaser, Cabergolina Aurobindo
- Luxembourg · Cabergoline Teva, Dostinex
- Latvia · Dostinex
- Malta · Cabergoline Aurobindo, Cabergoline Doc
- Netherlands · Cabergoline Aurobindo, Cabergoline Pch
- Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
- Poland · Dostinex
- Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
- Romania · Dostinex
- Sweden · Cabenex, Cabergoline Ratiopharm
- Slovakia · Cabest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/008a02b6-8510-4fec-81f1-edd3fb525bae GET /v1/drugs/008a02b6-8510-4fec-81f1-edd3fb525bae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"G02CB",
"G02CB03"
],
"strength": null,
"pa_number": "PA0822/126/001",
"substances": [
"Cabergoline"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "20/04/1995",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about cabergoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.